Protein-binding oligonucleotides: the next frontier in antithrombotic therapy.
Becker
Richard C
RC
Cardiovascular Thrombosis Center, Duke University Medical Center, Durham, NC 27715, USA. becke021@mc.duke.edu
D000818:Animals; D005343:Fibrinolytic Agents / Q000378:metabolism* / Q000627:therapeutic use*; D006801:Humans; D009841:Oligonucleotides / Q000378:metabolism* / Q000627:therapeutic use*; D011485:Protein Binding / Q000187:drug effects / Q000502:physiology
D005343:Fibrinolytic Agents; D009841:Oligonucleotides